- Home
- MDCX vs MODD Comparison
MDCX vs MODD Comparison
Compare MDCX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | MODD |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 33.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDCX | MODD |
|---|---|---|
| Price | $0.95 | $0.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 375.5K | 170.9K |
| Earning Date | 03-27-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.28 |
| 52 Week High | $8.94 | $1.29 |
Technical Indicators
Market Signals| Indicator | MDCX | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 21.00 | 55.67 |
| Support Level | $1.09 | $0.42 |
| Resistance Level | $1.29 | $0.49 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.17 | 59.55 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.